These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 16385868

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [New formulation--fewer tablets--optimal effect].
    Krankenpfl J; 2005; 43(7-10):249. PubMed ID: 16515318
    [No Abstract] [Full Text] [Related]

  • 3. New formulation of saquinavir (Fortovase) is more effective.
    Tam CW.
    Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Quadruple-2 protease inhibitors (PI)-therapy does not accelerate viral decay and suppression in PI-naive HIV-1 infected patients with severe immunosuppression and high viral load as compared with standard triple therapy.
    Portilla J, Boix V, Garcia-Henarejos JA, Llopis C, Martínez-Madrid O, Gimeno A, Sánchez-Paya J, Merino E.
    Int J STD AIDS; 2005 Dec; 16(12):807-10. PubMed ID: 16336763
    [Abstract] [Full Text] [Related]

  • 6. FDA notifications. Potential serious effect of combination saquinavir-ritonavir.
    AIDS Alert; 2010 Apr; 25(4):45-6. PubMed ID: 20564774
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir.
    Ananworanich J, Gayet-Ageron A, Ruxrungtham K, Chetchotisakd P, Prasithsirikul W, Kiertiburanakul S, Munsakul W, Raksakulkarn P, Tansuphasawadikul S, LeBraz M, Jupimai T, Ubolyam S, Schutz M, Hirschel B, Staccato Thailand Study Group.
    Antivir Ther; 2008 Apr; 13(3):375-80. PubMed ID: 18572750
    [Abstract] [Full Text] [Related]

  • 11. Searching for the right dose of ritonavir-saquinavir.
    TreatmentUpdate; 2001 Sep; 13(5):3. PubMed ID: 11768860
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Administer a protease inhibitor immediately? Proceeding strategically in HIV therapy].
    MMW Fortschr Med; 2000 Sep; 142(3 Suppl):6-7. PubMed ID: 10893947
    [No Abstract] [Full Text] [Related]

  • 20. [New protease inhibitor atazanavir. Simple administration--less resistance].
    MMW Fortschr Med; 2002 Aug 08; 144(31-32):47. PubMed ID: 12422733
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.